DEDICATE DOUBLE-BLIND EVALUATION OF DAPAGLIFLOZIN ON THE INCIDENCE OF CARDIOVASCULAR-ASSOCIATED EVENTS Trademark
Trademark Overview
On Thursday, January 26, 2012, a trademark application was filed for DEDICATE DOUBLE-BLIND EVALUATION OF DAPAGLIFLOZIN ON THE INCIDENCE OF CARDIOVASCULAR-ASSOCIATED EVENTS with the United States Patent and Trademark Office. The USPTO has given the DEDICATE DOUBLE-BLIND EVALUATION OF DAPAGLIFLOZIN ON THE INCIDENCE OF CARDIOVASCULAR-ASSOCIATED EVENTS trademark a serial number of 85525589. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Friday, December 14, 2012. This trademark is owned by Bristol-Myers Squibb Company. The DEDICATE DOUBLE-BLIND EVALUATION OF DAPAGLIFLOZIN ON THE INCIDENCE OF CARDIOVASCULAR-ASSOCIATED EVENTS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Medical and scientific research, namely, conducting clinical trials and clinical studies relating to pharmaceutical preparations for human use
General Information
| Serial Number | 85525589 |
| Word Mark | DEDICATE DOUBLE-BLIND EVALUATION OF DAPAGLIFLOZIN ON THE INCIDENCE OF CARDIOVASCULAR-ASSOCIATED EVENTS |
| Filing Date | Thursday, January 26, 2012 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Friday, December 14, 2012 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Medical and scientific research, namely, conducting clinical trials and clinical studies relating to pharmaceutical preparations for human use |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, January 30, 2012 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Bristol-Myers Squibb Company |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10154 |
Trademark Events
| Event Date | Event Description |
| Friday, December 14, 2012 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
| Friday, December 14, 2012 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Tuesday, July 10, 2012 | ASSIGNED TO EXAMINER |
| Friday, May 18, 2012 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, May 18, 2012 | NON-FINAL ACTION E-MAILED |
| Friday, May 18, 2012 | NON-FINAL ACTION WRITTEN |
| Saturday, May 5, 2012 | ASSIGNED TO EXAMINER |
| Monday, January 30, 2012 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Monday, January 30, 2012 | NEW APPLICATION ENTERED IN TRAM |
